Bluejay Diagnostics Retained Earnings Over Time
| BJDX Stock | USD 3.48 0.14 3.87% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bluejay Diagnostics Performance and Bluejay Diagnostics Correlation. Bluejay |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluejay Diagnostics. If investors know Bluejay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluejay Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (804.00) | Return On Assets (0.59) | Return On Equity (1.25) |
The market value of Bluejay Diagnostics is measured differently than its book value, which is the value of Bluejay that is recorded on the company's balance sheet. Investors also form their own opinion of Bluejay Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Bluejay Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluejay Diagnostics' market value can be influenced by many factors that don't directly affect Bluejay Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluejay Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluejay Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluejay Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Retained Earnings Analysis
Compare Bluejay Diagnostics and related stocks such as Bone Biologics Corp, Talis Biomedical Corp, and Nuwellis Retained Earnings Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | (6.5 K) | (6.5 K) | (6.5 K) | (7.6 K) | (12 M) | (25.9 M) | (46.9 M) | (59.2 M) | (63.6 M) | (67 M) | (68.9 M) | (70.5 M) | (72 M) | (80.9 M) | (76.9 M) |
| NUWE | (2 M) | (65.2 M) | (79.3 M) | (101 M) | (126.6 M) | (153.2 M) | (169 M) | (182.4 M) | (199.4 M) | (217.5 M) | (233.3 M) | (252.9 M) | (267.4 M) | (287.6 M) | (273.2 M) |
| HSCS | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (49.6 M) | (54.4 M) | (60.8 M) | (67.4 M) | (70.7 M) |
| TIVC | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (11.1 M) | (19.5 M) | (29.6 M) | (37.9 M) | (36 M) |
| NXL | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (61.2 M) | (64.6 M) | (70.7 M) | (72.4 M) | (77 M) | (80.9 M) |
| IRIX | (800 K) | (18.6 M) | (17.2 M) | (14.9 M) | (4.9 M) | (4.4 M) | (16.1 M) | (29 M) | (41.8 M) | (50.6 M) | (56.9 M) | (62.2 M) | (69.7 M) | (79 M) | (75.1 M) |
Bluejay Diagnostics and related stocks such as Bone Biologics Corp, Talis Biomedical Corp, and Nuwellis Retained Earnings description
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.My Equities
My Current Equities and Potential Positions
| Bluejay Diagnostics | BJDX |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.48
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.